Currently, cemented THA is considered the standard treatment option for advanced osteoarthritis in the elderly, with close to 90% of patients (over 75 years of age) receiving THA having a prosthesis life expectancy of 10-20 years. Uncemented hip prostheses have also been widely popular for some time and have been utilized more often in elderly patients, with some scholars claiming that uncemented devices have the following advantages: shorter operative time, reduced cardiorespiratory stress, and incidence of embolism. However, recent literature has shown that the advantages of uncemented prostheses over cemented ones are no longer evident in patients older than 75 years of age, and a retrospective study conducted by Troelsen showed that there was a higher revision rate for uncemented devices compared to cemented ones in the elderly population. Hip revisions present a relatively high operational challenge for the operator and are associated with a higher mortality rate, require a longer postoperative recovery time, and often require multiple surgeries for treatment. Therefore, how to circumvent hip revision in the elderly patient population remains challenging for the operator. There is a considerable body of literature showing an increasing trend in survival to hospital departure, but the generalizability of this data, all from their respective hospitals, is not very clear. MD et al. analyzed the factors affecting mortality and survival of primary total hip replacements in patients over 80 years of age undergoing joint replacement (cemented, uncemented, and hybrid). In particular, the factors affecting the risk of revision, as well as the causes of revision and mortality after primary arthroplasty were described, and the latest findings were published in the recent ClinOrthop Relat Res (2014). The investigators’ data were mainly based on the Finnish ArthroplastyRegister, 4777 arthroplasties performed in all 4509 patients with severe osteoarthritis from 1998-2009, and patient complications were mainly collected through a nationwide quality of survival registry, with revision surgery performed as the initial total Hip replacement failure criteria were statistically analyzed by survival risk analysis and COX regression analysis. The mean follow-up time was 4 years. Through the study, it was shown that uncemented arthroplasties have a higher early (within 1 year) revision rate than cemented arthroplasties, especially in women, and that the difference could not be explained by complications and prosthesis suppliers, and that periprosthetic fracture was also the leading postoperative complication of uncemented arthroplasties. The study also confirmed that there was no significant difference in survival at one year postoperatively, and that uncemented arthroplasties were slightly less likely than cemented and hybrid arthroplasties to have a 10-year survival rate. And it was shown that the surgical approach did not affect the mortality rate. With the above literature, the researchers finally concluded that the uncemented type cannot be utilized in patients over eighty years of age. However, more research is needed to confirm whether the higher early failure rate is related to the design of the prosthesis.